Mangalam Drugs & Organics submits copy of revise financial results

19 Jul 2013 Evaluate

Mangalam Drugs & Organics has submitted a copy of revise Financial Results for the quarter and year ended March 31, 2013. The heading of the first column change from 'Unaudited - 3 months ended - March 31, 2013' to 'Audited - 3 months ended - March 31, 2013 - refer note no. 2'. There is no change in any of the financial figures submitted earlier.

The above information is a part of company’s filings submitted to BSE.

Mangalam Drugs&Org. Share Price

106.90 2.10 (2.00%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.